Active Investments

Aledade

Private

Juno Therapeutics

Private

Doctor on Demand

Private

Grand Rounds

Private

ADVANCE Medical

Private

Hua Medicine

Private

Kyruus

Private

PowerVision

Private

Ariosa Diagnostics

Acquired by Roche

Castlight Health

Public (NYSE: CSLT)

Fate Therapeutics

Public (NASDAQ: FATE)

Zeltiq

Public (NASDAQ: ZLTQ)

Cerulean Pharma

Public (NASDAQ: CERU)

Achaogen

Public (NASDAQ: AKAO)

Intarcia Therapeutics

Private

Vitae Pharma

Private

Ironwood Pharma

Public (NASDAQ: IRWD)

Ironwood Pharma

Public (NASDAQ: IRWD)

Alumni Investments

Receptos

Public (NASDAQ: RCPT)

Ikaria

Acquired by Madison Dearborn

CodeRyte

Acquired by 3M

Sirna Therapeutics

Acquired by Merck

Ensure Medical

Acquired by Cordis

XenoPort

Public (NASDAQ: XNPT)

athenahealth

Public (NASDAQ: ATHN)

Illumina

Public (NASDAQ: ILMN)

Bryan Roberts Partner

Focus Areas: Healthcare IT, Biotechnology, Diagnostics, Medical Devices
Location: Palo Alto

Bryan Roberts, Ph.D. joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen (NASDAQ: AKAO), Castlight Health (NYSE: CSLT), and Ironwood Pharmaceuticals (NASDAQ: IRWD) and also serves on the Board of several other companies, including Ariosa Diagnostics, Doctor on Demand, Grand Rounds, Intarcia, Kyruus, and Zeltiq (NASDAQ: ZLTQ). Past investments include athenahealth (NASDAQ: ATHN), CodeRyte (acquired by 3M), Ikaria (acquired by Madison Dearborn), Illumina (NASDAQ: ILMN), Sirna Therapeutics (acquired by Merck) and Xenoport (NASDAQ: XNPT). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and is the only healthcare investor to rank on Forbes’ Midas List six times, 2008 – 2014.

Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his B.A. from Dartmouth College.

 

Active Companies

Aledade

Juno Therapeutics

Doctor on Demand

Grand Rounds

ADVANCE Medical

Hua Medicine

Kyruus

Kyruus is an enterprise healthcare provider solutions company that helps health systems optimize their Patient Access, Referral Management, and Care Coordination operations. Leveraging the Cloud and a proprietary Big Data approach, the company enables the integration of massive amounts of information to create a single source of truth of providers, and customizable protocols for referral and scheduling across all channels of patient engagement that improves patient access and patient experience. To find out how a Better Match = Better Care™, please visit http://www.kyruus.com

PowerVision

Ariosa Diagnostics

Castlight Health

Fate Therapeutics

Zeltiq

Cerulean Pharma

Achaogen

Intarcia Therapeutics

Vitae Pharma

Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient and effective platform for drug design and development.

Ironwood Pharma

Ironwood Pharma

Alumni Companies

Receptos

Ikaria

CodeRyte

Sirna Therapeutics

Ensure Medical

XenoPort

athenahealth

Illumina

Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.